BSE filing, NSE: WAKEFIT. Summary written from the filing by ALFA Finder's alert engine.
Wakefit Innovations Ltd: key numbers
- Share price
- ₹135.42
- Market cap
- ₹4,491 Cr
- Revenue (annual)
- ₹1,489 Cr
- Net profit (annual)
- ₹189.2 Cr
- P/E (TTM)
- 23.3×Sector 34.0×
- Promoter holding
- 37.07%+0.19% QoQ
- FII holding
- 14.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Wakefit Innovations Ltd
All →Wakefit Innovations Other Announcement
Wakefit Innovations Ltd has submitted the quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the period ended September 30, 2026.
Wakefit Innovations Employee Stock Options
Wakefit Innovations Limited has granted 2,25,442 employee stock options under its ESOP-2019 plan. These options are exercisable into equity shares at a price of Rs. 1 each.
Wakefit Innovations Management Change
Mr. Kunal Chandel, Senior Manager - Legal and Senior Management Personnel, has resigned from Wakefit Innovations Limited, effective from the close of business on September 24, 2026.
Wakefit Innovations Annual General Meeting
Wakefit Innovations Limited held its 10th Annual General Meeting on September 09, 2026, through video conferencing to discuss and adopt financial matters.
Wakefit Innovations Employee Stock Options
Wakefit Innovations Limited has allotted 3,13,521 equity shares to employees following ESOP exercise. This increases the company's total paid-up equity share capital to 33,16,45,219 shares.
Wakefit Innovations Annual General Meeting
Wakefit Innovations Limited has scheduled its 10th Annual General Meeting for September 09, 2026. The company also submitted its Annual Report for FY 2025-26.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.